Physician profile
Edward Scott Paxton
NPI 1083805675
$243,913.09
in general payments reported to CMS, 2019-2025
9 companies · $54K in 2025
The $54K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $10K · 2021: $47K · 2022: $38K · 2023: $27K · 2024: $35K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $96K · Royalty Or License: $12K · Travel and Lodging: $6,937 · Food and Beverage: $1,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $95,500.00 |
| Royalty Or License | $11,612.00 |
| Travel and Lodging | $6,936.81 |
| Food and Beverage | $1,662.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $135,604.09 | 2020-2025 | Blueprint Patient Specific Instrumentation, Simpliciti, Tornier Perform Anatomic Augmented Glenoid |
| Catalyst Orthoscience | $62,836.95 | 2020-2025 | Catalyst Fracture Shoulder System, Catalyst Total Csr, R1 Reverse Total Shoulder |
| Wright Medical Technology, INC. | $30,676.12 | 2019 | |
| Biedermann Motech, INC. | $14,459.95 | 2019-2025 | Distal Humerus Plate, Proximal Humerus Plating System |
| Linvatec Corporation | $137.52 | 2022 | |
| Zimmer Biomet Holdings, INC. | $125.57 | 2022 | |
| Acumed LLC | $35.49 | 2025 | Acumed |
| Encore Medical, Lp | $22.96 | 2024 | Djo Surgical |
| Smith+Nephew, INC. | $14.44 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Paxton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.